KeyBanc Reiterates Overweight Rating on Repligen (RGEN)
Tweet Send to a Friend
KeyBanc analyst Paul Knight reiterated an Overweight rating and $220.00 price target on Repligen (NASDAQ: RGEN).The analyst commented, "With 3Q24 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
